HIV Interventions: Biomedicine and the Traffic between Information and Flesh

Hardcover | November 12, 2009

byMarsha Rosengarten

not yet rated|write a review

Winner of the Sociology of Health and Illness Book Prize

HIV has changed in the presence of recent biomedical technologies. In particular, the development of anti-retroviral therapies (ARVs) for the treatment of HIV was a significant landmark in the history of the disease. Treatment with ARV drug regimens, which began in 1996, has enabled many thousands to live with the human immunodeficiency virus without progressing to AIDS. Yet ARVs have also been fraught with problems of regimen compliance, viral resistance, and iatrogenic disease. Besides intensifying the technological and ethical complexities of medicine, the drugs have also affected conceptions of risk and risk practices, in turn presenting new challenges for prevention.

In order to devise safer, more effective forms of treatment, prevention, and possibly cure, Marsha Rosengarten asserts, it is essential to understand the relationship between HIV, medical technologies, and ideas about the body. HIV is an entity that constitutes and is constituted by complex material and informational environments. Recognition of this two-way traffic between the medical science of HIV and the expression of HIV in individuals and societies provides a novel basis for devising new or supplementary modes of thinking about and intervening in the epidemic.

Through such diverse materials as drug advertisements, pill formulations, scientific articles, clinical trials, diagnostic test results, and viral imaging as well as interviews with those living and working with HIV, Rosengarten provides numerous demonstrations of how the entities comprising the HIV epidemic - bodies, viral resistance, diagnostic results, safe sex - are forged through dynamic relations.

These various phenomena challenge existing prevention models and raise social and ethical concerns about the impact of additional technologies such as HIV pre- and post-exposure prophylaxis and the promise of vaccines and microbicides.

HIV Interventions is relevant to those engaged in questions of the social and ethical dimensions of biomedicine, biotechnology, and genomics. Further, the specific focus of the project offers HIV practitioners - in the sciences and social sciences, in clinical research, clinical practice, social research, policy development and prevention education - new perspectives and analytic tools for intercepting a virus that continues to endure and, most critically, to change in the course of doing so.

Pricing and Purchase Info

$66.47 online
$68.95 list price
Ships within 1-3 weeks
Ships free on orders over $25

From the Publisher

Winner of the Sociology of Health and Illness Book PrizeHIV has changed in the presence of recent biomedical technologies. In particular, the development of anti-retroviral therapies (ARVs) for the treatment of HIV was a significant landmark in the history of the disease. Treatment with ARV drug regimens, which began in 1996, has enabl...

Marsha Rosengarten is a senior lecturer in sociology at Goldsmiths, University of London.

other books by Marsha Rosengarten

HIV Interventions: Biomedicine and the Traffic between Information and Flesh
HIV Interventions: Biomedicine and the Traffic between ...

Kobo ebook|May 1 2010

$25.29 online$32.81list price(save 22%)
Format:HardcoverDimensions:148 pages, 9.26 × 6.26 × 0.62 inPublished:November 12, 2009Publisher:University Of Washington PressLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:0295989599

ISBN - 13:9780295989594

Look for similar items by category:

Customer Reviews of HIV Interventions: Biomedicine and the Traffic between Information and Flesh

Reviews

Extra Content

Table of Contents

Acknowledgments1. Introduction: HIV, Information, and Flesh2. Imagination, Diagnostics, and the Materialization of HIV3. HIV: A Synergy of Biological Matter, Technological Matter, and Publics4. The "Informed Matter" of HIV Prevention5. The Human Host: Performative and Relational Difference6. Conclusion NotesBibliographyIndex

Editorial Reviews

Winner of the Sociology of Health and Illness Book PrizeHIV has changed in the presence of recent biomedical technologies. In particular, the development of anti-retroviral therapies (ARVs) for the treatment of HIV was a significant landmark in the history of the disease. Treatment with ARV drug regimens, which began in 1996, has enabled many thousands to live with the human immunodeficiency virus without progressing to AIDS. Yet ARVs have also been fraught with problems of regimen compliance, viral resistance, and iatrogenic disease. Besides intensifying the technological and ethical complexities of medicine, the drugs have also affected conceptions of risk and risk practices, in turn presenting new challenges for prevention.In order to devise safer, more effective forms of treatment, prevention, and possibly cure, Marsha Rosengarten asserts, it is essential to understand the relationship between HIV, medical technologies, and ideas about the body. HIV is an entity that constitutes and is constituted by complex material and informational environments. Recognition of this two-way traffic between the medical science of HIV and the expression of HIV in individuals and societies provides a novel basis for devising new or supplementary modes of thinking about and intervening in the epidemic.Through such diverse materials as drug advertisements, pill formulations, scientific articles, clinical trials, diagnostic test results, and viral imaging as well as interviews with those living and working with HIV, Rosengarten provides numerous demonstrations of how the entities comprising the HIV epidemic - bodies, viral resistance, diagnostic results, safe sex - are forged through dynamic relations.These various phenomena challenge existing prevention models and raise social and ethical concerns about the impact of additional technologies such as HIV pre- and post-exposure prophylaxis and the promise of vaccines and microbicides. HIV Interventions is relevant to those engaged in questions of the social and ethical dimensions of biomedicine, biotechnology, and genomics. Further, the specific focus of the project offers HIV practitioners - in the sciences and social sciences, in clinical research, clinical practice, social research, policy development and prevention education - new perspectives and analytic tools for intercepting a virus that continues to endure and, most critically, to change in the course of doing so.In this remarkable and timely work, Marsha Rosengarten makes the compelling argument that to approach the issue of HIV intervention as if information and flesh are distinct—-as if the task of intervention is simply to convince fleshy bodies to behave according to the information—-constrains our ability to think the processes and relationships at stake. Writing with admirable concision and clarity, she transfigures a theoretical terrain too long encumbered by such restrictive understandings in order to provide an alternative, nuanced perspective on how the HIV assemblage—-the virus, the diagnostic apparatuses, antiretroviral treatments, pharmaceutical trials and interests, human embodiment and wider responses to HIV—-consists of a myriad of processes that quite literally inform matter. Well beyond debates on 'performativity v matter' and 'technological v organic', this erudite work contains the best arguments I know for the political importance of thinking through the implications of such 'informed matter'. - Vikki Bell, Professor of Sociology, Goldsmiths, University of London